UDTR Global Radar

UDTR Global Rights of Nature Radar

Documentary registry of records detected across the scholarly, legal and institutional infrastructures monitored by UDTR.

A global documentary infrastructure designed to achieve the broadest verifiable and scientifically defensible coverage of the Rights of Nature.

← Back to Radar

Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus

Identification

Public canonical key
radar:r-45b29a3b8d75eafa7ee0ef5d5f349c7b
Authors
Cong Sun · Chu Xie · Xin‐Yan Fang · Dong‐Chun Hong · Haoyu Zhang · Ping Wu · Yina Liu · Guo‐Long Bu · De‐Hai Cao · Minyi Situ · Yong‐Jian Peng · Jing Wang · Guo‐Kai Feng · Qian Zhong · Zheng Liu · Mu‐Sheng Zeng
Reported year
2025
Reported language
en
Source type
article
First detected
2026-11-14T02:04:20.559729+00:00
Last metadata observation
2026-11-14T02:04:20.559729+00:00
Last HTTP verification
Not checked

Institutions reported by the source

Sun Yat-sen University Cancer Center · State Key Laboratory of Oncology in South China · Southern University of Science and Technology

Reported affiliation countries

CN

Documentary abstract — original language

Epstein‒Barr virus (EBV) is a ubiquitous gammaherpesvirus linked to a broad spectrum of malignancies and autoimmune diseases with no approved therapeutic drugs or vaccines. EBV infection relies on the viral glycoproteins gB and gHgL, which, together, function as the fusion apparatus, mediating viral recognition and membrane fusion in both epithelial and B cells. Despite discovering potent neutralizing antibodies targeting gB and gHgL, the heterogeneous antigen structures and distribution of multiple glycoproteins in the virion hinder rational vaccine design targeting this apparatus complex. In this study, Chimeric nanoparticles (Chimeric-NPs) are designed that co-display EBV fusion apparatus and induce significantly more neutralizing antibodies in mice and nonhuman primates than the cocktail counterparts. It is further demonstrated that the Chimeric-NPs elicited neutralizing antibodies predominantly targeting gB, closely mimicking the antibody induction pattern by the whole EBV virion. Additionally, single-BCR sequencing is used to analyze the B cell response to Chimeric-NP, and a novel gB neutralizing antibody Fab5 targeting a new vulnerable site EBV gB is identified. These findings provide novel candidates and vaccine design strategies for EBV and reveal the underlying mechanisms of antibody induction and immune response regulation by chimera vaccines, with potential implications for all multi-antigen-harbored pathogens.

Identifiers

OPENALEX
https://openalex.org/W4414812902
DOI
10.1002/adma.202507012
PMID
https://pubmed.ncbi.nlm.nih.gov/41045177

Documentary context

Documentary family
article
Source-reported types
article
Publishers
Wiley

Entity mentions are not evidence of legal recognition. Jurisdiction studied is separate from author affiliation country.

Sources

OpenAlex · Record 1

Cite this reference

Cong Sun; Chu Xie; Xin‐Yan Fang; Dong‐Chun Hong; Haoyu Zhang; Ping Wu; Yina Liu; Guo‐Long Bu; De‐Hai Cao; Minyi Situ; Yong‐Jian Peng; Jing Wang; Guo‐Kai Feng; Qian Zhong; Zheng Liu; Mu‐Sheng Zeng. Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus. 2025. https://doi.org/10.1002/adma.202507012

JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·

APA, Chicago, ISO 690: bibliographic formats using available fields. OSCOLA / Bluebook: structured data only; full legal citation compliance is not claimed without verification of required elements.

APA
Cong Sun; Chu Xie; Xin‐Yan Fang; Dong‐Chun Hong; Haoyu Zhang; Ping Wu; Yina Liu; Guo‐Long Bu; De‐Hai Cao; Minyi Situ; Yong‐Jian Peng; Jing Wang; Guo‐Kai Feng; Qian Zhong; Zheng Liu; Mu‐Sheng Zeng. (2025). Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus. https://doi.org/10.1002/adma.202507012
Chicago
Cong Sun; Chu Xie; Xin‐Yan Fang; Dong‐Chun Hong; Haoyu Zhang; Ping Wu; Yina Liu; Guo‐Long Bu; De‐Hai Cao; Minyi Situ; Yong‐Jian Peng; Jing Wang; Guo‐Kai Feng; Qian Zhong; Zheng Liu; Mu‐Sheng Zeng. Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus. 2025. https://doi.org/10.1002/adma.202507012
ISO 690
Cong Sun; Chu Xie; Xin‐Yan Fang; Dong‐Chun Hong; Haoyu Zhang; Ping Wu; Yina Liu; Guo‐Long Bu; De‐Hai Cao; Minyi Situ; Yong‐Jian Peng; Jing Wang; Guo‐Kai Feng; Qian Zhong; Zheng Liu; Mu‐Sheng Zeng. Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus. 2025. https://doi.org/10.1002/adma.202507012

Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31

UDTR Global Rights of Nature Legal Library. Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus. Documentary record: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-45b29a3b8d75eafa7ee0ef5d5f349c7b/ · Last HTTP verification: not performed

Report a correction

Frozen-version metadata

Research dossiers and documentary relations

Source roles

Bibliographic / original publication source · https://doi.org/10.1002/adma.202507012

An authority link alone does not verify a legal claim. Abstracts and full texts remain subject to their source terms.

Documentary status

Relevance pending

Library

This identity is not yet included in the Legal Library.

UDTR Global Rights of Nature Legal Library